Search - tctmd.com

Displaying 81 - 100 of 191

Sort: Relevancy | Date

Presentation TCT 2014

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Thomas F. Luscher

September 13, 2014

Presentation TCT 2014

Current Status of Advanced Hypertension Treatment in the United States

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Michael A. Weber

September 13, 2014

Presentation TCT 2014

What it Means to Have (and Be) a Hypertension Referral Center

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, C. Venkata S. Ram

September 13, 2014

Presentation TCT 2014

Workup and Treatment of Hypertension: From A to Z

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Atul Pathak

September 13, 2014

Presentation TCT 2014

Essentials of Mapping the Renal Nerves In Vivo

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Jie Wang

September 13, 2014

Presentation TCT 2014

Essentials of Chemical Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Tim A. Fischell

September 13, 2014

Presentation TCT 2014

Essentials of Ultrasound Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Joost Daemen

September 13, 2014

Presentation TCT 2014

Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar)

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn

September 13, 2014

Presentation TCT 2014

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Felix Mahfoud

September 13, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

Presentation TCT 2014

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

There Is Hope for Producing Preclinical Models for Successful Device Development

Presenter: Gregory J. Wilson

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

Advertisement

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Current Status of Advanced Hypertension Treatment in the United States

What it Means to Have (and Be) a Hypertension Referral Center

Workup and Treatment of Hypertension: From A to Z

Essentials of Mapping the Renal Nerves In Vivo

Essentials of Chemical Ablation

Essentials of Ultrasound Ablation

Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar)

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

There Is Hope for Producing Preclinical Models for Successful Device Development

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Renal Nerve Microanatomy - The Foundation for RDN Technologies

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content